öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

±±¾©´óѧҩѧԺÁÙ´²Ò©Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØË¶Ê¿Ñо¿Éúµ¼Ê¦ÐÅÏ¢£ºÉÛºê

±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2016-06-22

ÉÛºê

ÁªÏµµç»°£º010-82805020

µç×ÓÓÊÏ䣺h_shao@163.com

Éۺ긱½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦£¬±±¾©´óѧҩѧԺҩʹÜÀíÓëÁÙ´²Ò©Ñ§Ïµ¸±Ö÷ÈΡ¢ÖйúÒÅ´«Ñ§»á»áÔ±¡¢International Hemp Association»áÔ±¡¢Öйú¸ßµÈѧУÒôÀÖ½ÌÓýѧ»á»áÔ±¡¢±±¾©Êп¹°©Ð­»áÒ©ÎïÖÎÁÆöλÔÓéÀֵǼÈë¿ÚÏÂÔØÎ¯Ô±»áίԱ¡¢Ò©Îï²»Á¼·´Ó¦ÔÓÖ¾±àί¡£

¹¤×÷ѧϰ¾­Àú£ºËÄ´¨´óѧÉúÎïϵÀíѧѧʿ£»±±¾©Ò½¿Æ´óѧҩѧԺÀíѧ˶ʿ¡¢Àíѧ²©Ê¿£»±±¾©´óѧ»ù´¡Ò½Ñ§ÔºÉúÎïÒÅ´«Ñ§½ÌÑÐÊÒ½²Ê¦¡¢¸±½ÌÊÚ£»±±¾©´óѧҩѧԺҩʹÜÀíÓëÁÙ´²Ò©Ñ§Ïµ¸±½ÌÊÚ¡¢Ïµ¸±Ö÷ÈΣ»ÃÀ¹úKentucky´óѧ·ÃÎÊѧÕß¡£
»ñ½±Çé¿ö£º2008Äê¶ÈÔÚ¡°ÃæÏòÒ½ÔºÐèÇó£¬Í»³öÁÙ´²ÓÃÒ©ÌØÉ«£¬ÎªÒ½Ò©ÊÂÒµÅàÑø¸ß²ã´ÎÁÙ´²Ò©Ñ§È˲š±ÏîÄ¿ÉÏÒÔµÚ¶þÍê³ÉÈË»ñ±±¾©´óѧҽѧ²¿½Ìѧ³É¹û½±¡¢2011Äê¶È»ñ±±¾©´óѧҽѧ²¿½Ìѧ¹ÜÀíÓÅÐã½±¡£

Ö÷ÒªÑо¿·½Ïò£ºÒ©ÎïÒÅ´«Ñ§Óë¸öÌ廯ÓÃÒ©¡¢ÁÙ´²Ò©Ñ§½ÌѧÓëʵ¼ùÌåϵÑо¿

ÔÚÑпÎÌ⣺

1£©¿Æ¼¼²¿£º±±¾©´óѧ×ÛºÏÐÔ´´ÐÂÒ©ÎïÑо¿¿ª·¢¼¼Êõ´óƽ̨£¬Ò©Îï´úл×ÓÆ½Ì¨£º»ùÒò¶à̬ÐÔÓëÒ©Îï´úл±íÐÍÏà¹ØÐÔµÄÑо¿

2£©¿Æ¼¼²¿£º¡°Ê®¶þÎ塱֨´óÐÂÒ©´´ÖÆ×¨Ï1Àà°ÐÏò¿¹Ö×ÁöÐÂÒ©ÒÒÍéÎøßøµÄÁÙ´²Ñо¿

±àÖø¼°·¢±íÎÄÕ£ºÖ÷±à/²Î±à¶à²¿Öø×÷£º[1] Éۺ꣬ÄôСÑ࣬ÓÚ½à. µÚÎåÕ ҩÎïÁ÷Ðв¡Ñ§ÓëÒ©Æ·²»Á¼·´Ó¦¼à²â£»µÚÆßÕ ҩѧÐÅÏ¢ÓëÒ©ÎïÖÎÁÆÑ§. ÁÙ´²Ò©ÎïÖÎÁÆÑ§£¨Àî¿¡Ö÷±à£© £¨ÎÀÉú²¿¡°Ê®Ò»Î塱¹æ»®½Ì²Ä£©£¬ÈËÃñÎÀÉú³ö°æÉ磬2007£¬pp89-104£»pp114-127.

[2] Éۺ꣨Ö÷Ò룩. ÁÙ´²ÓÃÒ©°²È«Ö¸ÄÏ. ±±¾©£ºÈËÃñÎÀÉú³ö°æÉ磬2010.7.·¢±íÎÄÕÂÈçÏ£º

[1] Bao NJ, Shao H*, Nie XY, Wu YP, Yan Q, Li XX, Yang W, Wang N, Zheng K, Wei YH, Shi LW. Analysis of the status of clinical pharmacist pilot training in Chinese hospitals. Journal of Chinese Pharmaceutical Sciences 2011; 20(4):410-414.

[2] ¹ØÓ±×¿£¬ÉÛºê*. ÎÒÔº²¡·¿ÍËÒ©Çé¿ö¼°Ïà¹ØÓÃÒ©²î´í·ÖÎö. ÖйúÒ©·¿2011; 22(17):1620-1621.

[3] ÕÅÑÇͬ£¬ÕÅ»ª£¬ÑîÀòƼ£¬Éۺ꣬Àî¿ÉÐÀ£¬Ëï´º»ª. ABCB1ºÍCYP3A5»ùÒò¶à̬ÐÔ¶Ô»·æßËØÑªÒ©Å¨¶ÈµÄÓ°Ïì. ÖйúҩѧÔÓÖ¾2011; 46(5):368-373.

[4] κÑ޺죬ÉÛºê*£¬ÄôСÑ࣬ÑîΡ£¬ÍõÄþ£¬Ö£¿­£¬°üÄþ½®£¬ÀîϲÎ÷£¬ÎâÓÀÅ壬ʷ¼ÎÄ. ÎÒ¹úÁÙ´²Ò©Ê¦¹¤×÷ÏÖ×´Óë·ÖÎö. ÖйúÐÂÒ©ÔÓÖ¾ 2011; 20(9):87-91.

[5] ËïÓ­ç÷, ÕÅÑÇͬ, ÉÛºê*, ÁõÀÙ, ÑîÀöƼ, Ëï´º»ª, ʷ¼ÎÄ. ÎÒÔºÐÄÄڿƲ¡·¿2005-2009Ä꿹¸ßѪѹҩӦÓ÷ÖÎö. ÖйúÒ©·¿ 2011; 22(6):504-508.

[6] Âí×Ó¾², ÉÛºê*, Õ罡´æ. ÎÒÔº169Àý÷Ų¿¹ÇÕÛÊÖÊõΧÊÖÊõÆÚÓ¦ÓõͷÖ×Ó¸ÎËØµÄÁÙ´²ÆÀ¼Û. ÖйúÒ©·¿ 2010; 21(40):3787-3789.

[7] ³ÂÄþ, ÉÛºê*. ÎÒÔºÍâ¿Æ3ÖÖÇå½àÊÖÊõÔ¤·ÀÐÔÓ¦Óÿ¹¾úÒ©Îïµ÷²é·ÖÎö. ÖйúÒ©·¿ 2010; 21(34):3195-3197.

[8] ÁõÑþ£¬ÑîÀòƼ£¬ÉÛºê*.ÂÈßÁ¸ñÀ×ÁªºÏ°¢Íз¥ËûÍ¡ÖÎÁÆÈ±ÑªÐÔÐÄÄÔѪ¹Ü¼²²¡µÄϵͳÆÀ¼Û. ÖйúÒ©·¿ 2010; 21(24):2283-2286.

[9] Li D£¬Shao H*. A study of drug therapy problems in pharmaceutical care. Journal of Chinese Pharmaceutical Sciences 2009; 18(4):54-357.

[10] ÁõÃô£¬ÀîÖÒ¶«£¬ÉÛºê*. ´Ó±û»ùÁòÑõà×ल»Á¼·´Ó¦µÄʶ±ðÓë¸ÉԤ̸ҩʦµÄÁÙ´²Ò©Ñ§Êµ¼ù. ÖйúÐÂÒ©ÔÓÖ¾ 2009; 18(22):2189-2192

[11] Cao Y£¬Yang W£¬Lin XW£¬Shao H*. Impact of pharmaceutical intervention on the rational use of antibiotics. Journal of Chinese Pharmaceutical Sciences 2009; 18(3):283-286.

[12] ÖÓÐñÀö£¬ÕÅÏàÁÖ£¬ÕÔÀò£¬°×²¨£¬ÉÛºê*. Real-time PCR·¨¼ì²âÉöÒÆÖ²»¼ÕßÍâÖÜѪÁܰÍϸ°û´Î»ÆàÑßʺËÜÕËáÍÑÇâø»ùÒò±í´ï. ÖйúҩѧÔÓÖ¾ 2009; 44(9):649-653

[13] ÁÖÏþö©£¬ÉÛºê*£¬ÄôСÑ࣬ËïÓ­ç÷£¬ÕÅÀÖÆ¼£¬ÀîÓñÕ䣬¹Ë½¡. ¼¡ôûÇå³ýÂʶԴó¼ÁÁ¿¼×°±µûßÊ»¯ÁÆÖÐѪҩŨ¶ÈµÄÓ°Ïì. ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆÑ§ 2009; 14(3):319-322.

[14] ÄôСÑà; ÖÜÓ±; ¶­ÐÀºì; ´ÞÒ»Ãñ; ÉÛºê*; ʷ¼ÎÄ. ÃÅÕïÏû»¯ÐÔÀ£ÑñºÍÂýÐÔθÑ×ÓÃÒ©·ÖÎö. ÖйúҩѧÔÓÖ¾ 2009; 44(1):72-74.

[15] Ryan M, Shao H*, Yang L, Nie XY, Zhai SD, Shi LW, and Lubawy W. Clinical Pharmacy Education in China. American Journal of Pharmaceutical Education 2008; 72(6):A129. ¡¾SCIÊÕ¼¡¿

[16] ÀîÏþƽ, ÉÛºê*, Ñîɺ,ʷ¼ÎÄ. ±±¾©ÊÐ22¼ÒÒ½ÔºÁÙ´²Ò©Ñ§·þÎñ¶ÔÏóÂúÒâ¶Èµ÷²é. ҩѧʵ¼ùÔÓÖ¾ 2008; 26(05):378-381.

[17] Zhang YT, Yang LP, Shao H*, Li KX, Sun CH, and Shi LW. ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients. British Journal of Clinical Pharmacology 2008; 66(2):240-246.¡¾SCIÊÕ¼¡¿

[18] ÀîÏþƽ£¬ÉÛºê*£¬Ñîɺ£¬Ê·Â¼ÎÄ. Ó¦Óòã´Î·ÖÎö·¨È·¶¨ÁÙ´²Ò©Ñ§Á¿»¯ÆÀ¹ÀÌåϵָ±êµÄÈ¨ÖØ. Öйúҩʦ 2008; 11(8):958-960.

[19] Éۺ꣬ʷ¼ÎÄ. ÁÙ´²Ò©Ê¦ÅàÑøÍ¾¾¶Óë·½ÏòµÄ˼¿¼. Öйú´¦·½Ò© 2008.3 No.72:48-49.

[20] ±å溣¬ÖÜҵƽ£¬³ÂÖ¾¸Õ£¬Õ罡´æ£¬ÉÛºê*. ¸ßЧҺÏàÉ«Æ×·¨²â¶¨ÈËѪÇåÓÎÀëôǸ¬°±ËáµÄº¬Á¿. ÖйúҽԺҩѧÔÓÖ¾ 2008; 28(4):271-273.

[21] ÉÛºê. ÃÀ¹úÁÙ´²Ò©Ê¦ÅàÑøÄ£Ê½³õ̽. ÖйúÐÂÒ©ÔÓÖ¾ 2008; 17(1):79-82.

[22] ÍõÖ¾ºê£¬ÕÅÑÇͬ£¬ÉÛºê*. ÁÙ´²Ò©Ê¦ÔÚÁÙ´²Â·¾¶ÖеÄ×÷ÓÃ. ÖйúÒ©Ê 2007; 21(12):1019-1022.

[23] ÀîÏþƽ; ÉÛºê*; ÌÆÖÒæÃ; ´ïÍßÈÊÔö; Ñîɺ; ʷ¼ÎÄ. ¹úÍâ52Ëù´óѧÁÙ´²Ò©Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØÑо¿Éú½ÌѧÌåϵµÄ±È½ÏÑо¿. ÖйúÒ©Ê 2007; 21(11): 933-938.

[24] ÓÚ½à; ÉÛºê*; ÄôСÑà; ¹ù½ð·ï; ÖÜÓ±; ´ÞÒ»Ãñ; ʷ¼ÎÄ. CYP2C19»ùÒò¶à̬ÐÔ¶Ôñ²ðﻼÕß±ûÎìËáѪҩŨ¶ÈµÄÓ°Ïì. ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆÑ§ 2007; 12(6):700-704.

[25] ³ÂÐÀ; лÏþ»Û; ÉÛºê; ʷ¼ÎÄ. ÎÒУÈýÄêÖÆÁÙ´²Ò©Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØË¶Ê¿Ñо¿ÉúÅàÑøÖ®Ì½ÌÖ. ÖйúÒ©Ê 2007; 21(1): 61-62.

Ïà¹Ø»°Ìâ/ÁÙ´² ҩѧ Ò©Îï ÐÂÒ© »ùÒò

öλÔÓéÀÖ(xinhui)¹Ù·½ÍøÕ¾_öλÔÓéÀÖappÏÂÔØÈë¿Ú